Does Memantine induce bradycardia? A study in the French Pharmaco Vigilance Database

Pharmacoepidemiology and Drug Safety

Volumn 17, Issue 9, 2008, Pages 877-881

  Gallini, Adeline ^a,b   Sommet, Agnès ^a,b   Montastruc, Jean Louis ^a,b  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Adverse drug reaction; Alzheimer's disease; Bradycardia; Memantine; Pharmacoepidemiology

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DONEPEZIL; GALANTAMINE; MEMANTINE; RIVASTIGMINE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRADYCARDIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; DATA BASE; DESCRIPTIVE RESEARCH; DRUG RESPONSE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; ECG ABNORMALITY; FEMALE; HEART FAILURE; HEART RATE; HUMAN; HYPOTENSION; MALAISE; MALE; OBSERVATIONAL STUDY; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; SIDE EFFECT; SUDDEN DEATH; SYNCOPE;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; BRADYCARDIA; DATABASES, FACTUAL; FEMALE; FRANCE; HUMANS; MALE; MEMANTINE; MIDDLE AGED;

EID: 52949084635     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1620     Document Type: Article

References (14)

1. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366(9503): 2112-2117.
2. Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet 2006; 368(9533): 387-403.
3. Memantine. In Martindale: The Complete Drug Reference, 35th edition. The Pharmaceutical Press: London, 2007; 329.
4. Memantine. In Meyler's Side Effects of Drugs, 15th edition. Elsevier: Amsterdam, 2006; 2250.
5. Moore N, Noblet C, Kreft-Jais C, et al. French pharmacovigilance database system: examples of utilization [in French]. Therapie 1995; 50(6): 557-5562.
6. Spreux A, Baldin B, Chichmanian RM. Pharmacovigilance in practice [in French). Transfus Clin Biol 1999; 6(4): 254-259.
7. Begaud B, Evreux JC, Jouglard J, Lagier G. Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France. Therapie 1985; 40: 111-118.
8. Machado BH. Neurotransmission of the cardiovascular reflexes in the nucleus tractus solitarii of awake rats. Ann N Y Acad Sci 2001; 940: 179-196.
9. Haibara AS, Colombari E, Chianca DA, et al. NMDA receptors in NTS are involved in bradycardic but not in pressor response of chemoreflex. Am J Physiol 1995; 269(4Pt2): H1421-H1427.
10. Huang CF, Su MJ. Positive inotropic action of NMDA receptor antagonist (+)-MK801 in rat heart. J Biomed Sci 1999; 6(6): 387-398.
11. Leung JC, Travis BR, Verlander JW, et al. Expression and developmental regulation of the NMDA receptor subunits in the kidney and cardiovascular system. Am J Physiol Regal Integr Comp Physiol 2002; 283(4): R964-R971.
12. Tariot PN, Farlow MR, Grossberg GT, et al. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA 2004; 291(3): 317-324.
13. Wilson AM, Thabane L, Holbrook A. Application of data mining techniques in pharmacovigilance. Br J Clin Pharmacol 2004; 57(2): 127-134.
14. Kennedy DL, Goldman SA, Lillie RB. Spontaneous reporting in the United States. In Pharmacoepidemiology, 3rd edition. Stron BL (ed.). Wiley: New York, 2000; 152-174.